Grant: Engage Grants Program
Ryerson University
$25,000.00
A novel genetically engineered oilseed: A controlled assessment of two bioactive substances intended for commercialization
FY 2015-16
Summary
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are essential fatty acids that are produced only by aquatic plants (these compounds are not found in terrestrial plants) and are critical to our neurological and cardiovascular health. However, we (and indeed all other vertebrates) do not make these compounds very efficiently, so they must, in large part, be obtained from the diet (e.g. by eating fish and/or fish oil pills). Sourcing EPA and DHA from wild fish is quickly becoming both environmentally- and economically-unsustainable. As a solution to this problem, oilseed crops (such as canola and camelina) have been genetically engineered (GE) to produce EPA and DHA at levels similar to fish oil, which can then be used by several different industries (nutraceuticals, aquaculture) to replace fish oil. Linnaeus Plant Sciences (LPS) is keen to grow and commercialize GE camelina in Canada, and would be the first to do so on a commercial scale globally. However, commercialization will require testing to demonstrate that introducing GE camelina to the Canadian agroecosystem will not unduly benefit crop pests. We propose to conduct the initial research required to begin the commercialization process, understand the effects, and transfer this key knowledge to LPS. To begin the assessment process, we plan to investigate the effect of EPA and DHA on the biology of crop pests.
Program
Engage Grants Program
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
491882-2015
Name nom
Arts, Michael
Department département
Chemistry and Biology
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
100
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Agriculture and primary food production
Area of application fr
Agriculture et produits alimentaires primaires
Research subject code
4712
Research subject group en
Evolution and ecology
Research subject group fr
Évolution et écologie
Research subject en
Plant-animal interaction
Research subject fr
Interaction plante-animal
Partie
1
Nb partie
1
Application title
A novel genetically engineered oilseed: A controlled assessment of two bioactive substances intended for commercialization
Keyword
NSERC
Application summary
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are essential fatty acids that are produced only by aquatic plants (these compounds are not found in terrestrial plants) and are critical to our neurological and cardiovascular health. However, we (and indeed all other vertebrates) do not make these compounds very efficiently, so they must, in large part, be obtained from the diet (e.g. by eating fish and/or fish oil pills). Sourcing EPA and DHA from wild fish is quickly becoming both environmentally- and economically-unsustainable. As a solution to this problem, oilseed crops (such as canola and camelina) have been genetically engineered (GE) to produce EPA and DHA at levels similar to fish oil, which can then be used by several different industries (nutraceuticals, aquaculture) to replace fish oil. Linnaeus Plant Sciences (LPS) is keen to grow and commercialize GE camelina in Canada, and would be the first to do so on a commercial scale globally. However, commercialization will require testing to demonstrate that introducing GE camelina to the Canadian agroecosystem will not unduly benefit crop pests. We propose to conduct the initial research required to begin the commercialization process, understand the effects, and transfer this key knowledge to LPS. To begin the assessment process, we plan to investigate the effect of EPA and DHA on the biology of crop pests.